Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Spacek

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Frontiers in Neuroinformatics|February 10, 2009
Python for large-scale electrophysiologyMartin Spacek, Tim Blanche, Nicholas Swindale
Casopis Lekaru Ceskych|December 3, 2011
[Conflict of interest: the World Medical Association statement]Lydie Fialová, Martin Spacek, Pavel Vychytil
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 10, 2010
Heat-shock protein expression in leukemiaLucie Sedlackova, Martin Spacek, Ernst Holler, et al.
Journal of Receptor and Signal Transduction Research|April 27, 2010
Expression of heat shock protein 70 and NKG2D ligands in acute myeloid leukemia cell linesIlona Hromadnikova, Roman Volchenkov, Lucie Sedlackova, et al.
Acta Haematologica|July 8, 2010
Can we use EBV-DNA monitoring to predict disease relapse in EBV-positive hodgkin lymphoma patients?Martin Spacek, P Hubacek, J Markova, et al.
Leukemia Research|August 11, 2007
Identification of a novel, transactivation-defective splicing variant of p53 gene in patients with chronic lymphocytic leukemiaSona Pekova, Radek Cmejla, Lukas Smolej, et al.
Folia Microbiologica|July 17, 2012
Prevalence of chromosomally integrated HHV-6 in patients with malignant disease and healthy donors in the Czech RepublicPetr Hubacek, Alena Hrdlickova, Martin Spacek, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 15, 2010
Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patientsMartin Spacek, Petr Hubacek, Jana Markova, et al.
Leukemia Research|May 7, 2011
No association between the TP53 codon 72 polymorphism and risk or prognosis of Hodgkin and non-Hodgkin lymphomaOndrej Havranek, Martin Spacek, Petr Hubacek, et al.
Leukemia & Lymphoma|November 26, 2020
CD31/PECAM-1 impacts engraftment, growth and spread of mantle cell lymphoma cells and positively correlates with extramedullary involvementPetra Vockova, Jan Molinsky, Magdalena Klanova, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Frontiers in Neuroinformatics|February 10, 2009
Python for large-scale electrophysiologyMartin Spacek, Tim Blanche, Nicholas Swindale
Casopis Lekaru Ceskych|December 3, 2011
[Conflict of interest: the World Medical Association statement]Lydie Fialová, Martin Spacek, Pavel Vychytil
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|August 10, 2010
Heat-shock protein expression in leukemiaLucie Sedlackova, Martin Spacek, Ernst Holler, et al.
Journal of Receptor and Signal Transduction Research|April 27, 2010
Expression of heat shock protein 70 and NKG2D ligands in acute myeloid leukemia cell linesIlona Hromadnikova, Roman Volchenkov, Lucie Sedlackova, et al.
Acta Haematologica|July 8, 2010
Can we use EBV-DNA monitoring to predict disease relapse in EBV-positive hodgkin lymphoma patients?Martin Spacek, P Hubacek, J Markova, et al.
Leukemia Research|August 11, 2007
Identification of a novel, transactivation-defective splicing variant of p53 gene in patients with chronic lymphocytic leukemiaSona Pekova, Radek Cmejla, Lukas Smolej, et al.
Folia Microbiologica|July 17, 2012
Prevalence of chromosomally integrated HHV-6 in patients with malignant disease and healthy donors in the Czech RepublicPetr Hubacek, Alena Hrdlickova, Martin Spacek, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|December 15, 2010
Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patientsMartin Spacek, Petr Hubacek, Jana Markova, et al.
Leukemia Research|May 7, 2011
No association between the TP53 codon 72 polymorphism and risk or prognosis of Hodgkin and non-Hodgkin lymphomaOndrej Havranek, Martin Spacek, Petr Hubacek, et al.
Leukemia & Lymphoma|November 26, 2020
CD31/PECAM-1 impacts engraftment, growth and spread of mantle cell lymphoma cells and positively correlates with extramedullary involvementPetra Vockova, Jan Molinsky, Magdalena Klanova, et al.
Pageof 2